IRIS
NOBILI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.063
AS - Asia 1.926
EU - Europa 1.745
SA - Sud America 665
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
AN - Antartide 1
Totale 6.451
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.985
SG - Singapore 1.000
RU - Federazione Russa 896
BR - Brasile 546
CN - Cina 340
IE - Irlanda 325
VN - Vietnam 309
SE - Svezia 199
IT - Italia 145
HK - Hong Kong 70
IN - India 52
AR - Argentina 46
DE - Germania 43
CA - Canada 36
GB - Regno Unito 36
BD - Bangladesh 33
ID - Indonesia 29
MX - Messico 26
EC - Ecuador 21
AT - Austria 18
PL - Polonia 15
PY - Paraguay 14
CO - Colombia 13
IQ - Iraq 13
TR - Turchia 13
ZA - Sudafrica 13
UA - Ucraina 12
ES - Italia 9
PK - Pakistan 9
FI - Finlandia 7
KE - Kenya 7
MA - Marocco 7
UY - Uruguay 7
VE - Venezuela 7
LT - Lituania 6
PE - Perù 6
TN - Tunisia 6
BE - Belgio 5
FR - Francia 5
JM - Giamaica 5
KR - Corea 5
RO - Romania 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
JP - Giappone 4
MY - Malesia 4
NL - Olanda 4
SA - Arabia Saudita 4
AL - Albania 3
BH - Bahrain 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
JO - Giordania 3
NP - Nepal 3
TH - Thailandia 3
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
HN - Honduras 2
IR - Iran 2
KZ - Kazakistan 2
MN - Mongolia 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BM - Bermuda 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
GI - Gibilterra 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PW - Palau 1
RS - Serbia 1
Totale 6.451
Salva come PNG Salva come JPEG
Città #
Singapore 701
San Jose 336
Dublin 325
Princeton 172
Beijing 162
Dallas 140
Ashburn 135
Santa Clara 124
Ho Chi Minh City 113
Altamura 90
Jacksonville 81
Hanoi 74
Hong Kong 65
Wilmington 56
Los Angeles 50
São Paulo 50
New York 36
Buffalo 34
Redondo Beach 33
Council Bluffs 30
Rio de Janeiro 24
Chandler 22
Moscow 21
Nuremberg 19
Chicago 18
The Dalles 17
Norwalk 16
Curitiba 15
Haiphong 15
London 14
Mexico City 14
Chennai 13
Denver 12
Dong Ket 12
Montreal 11
Guayaquil 10
Orem 10
St Louis 10
Manchester 9
Mumbai 9
Toronto 9
Brooklyn 8
Munich 8
Porto Alegre 8
San Francisco 8
Johannesburg 7
Milan 7
Phoenix 7
Thái Bình 7
Vienna 7
Warsaw 7
Belo Horizonte 6
Boston 6
Frankfurt am Main 6
Hangzhou 6
Istanbul 6
Montevideo 6
Nairobi 6
Santa Fe 6
Stockholm 6
Uberlândia 6
Bauru 5
Brasília 5
Brussels 5
Charlotte 5
Fortaleza 5
Guarulhos 5
New Delhi 5
Philadelphia 5
Phủ Lý 5
Salvador 5
Seoul 5
Sorocaba 5
Ankara 4
Atlanta 4
Brno 4
Buenos Aires 4
Bắc Giang 4
Da Nang 4
Dhaka 4
Hefei 4
Helsinki 4
Hải Dương 4
José C. Paz 4
Osasco 4
Poplar 4
Recife 4
Romola 4
Santo André 4
São José dos Pinhais 4
Tashkent 4
Amsterdam 3
Aparecida de Goiânia 3
Araraquara 3
Asunción 3
Baghdad 3
Belford Roxo 3
Bình Dương 3
Calgary 3
Campinas 3
Totale 3.400
Salva come PNG Salva come JPEG
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 798
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 150
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 111
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action 110
Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents 109
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) 104
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development 98
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study 96
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 94
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: A first insight 92
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy 91
Efficacy evaluation of plant products in the treatment of erectile dysfunction related to diabetes 89
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 87
Cellular pharmacology of gemcitabine 86
Druggable targets in pancreatic adenocarcinoma 86
Natural compounds for cancer treatment and prevention 83
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds 81
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 81
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 79
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 79
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 79
Chronic inflammation in urothelial bladder cancer 78
HLA-G 3'UTR polymorphisms impact the prognosis of stage II-III CRC patients in fluoropyrimidine-based treatment 77
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 76
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 75
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 75
Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia 75
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer 74
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 73
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 73
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions 72
Insights into the role of matrix metalloproteinases in precancerous conditions and in colorectal cancer 72
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 71
Prognostic factors in primary and iterative surgery of colorectal liver metastases 71
PNN and KCNQ1OT1 Can Predict the Efficacy of Adjuvant Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer Patients 71
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy 70
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: A pilot study 70
Establishment and characterization of a new spontaneously immortalized ER -/PR -/HER2 + human breast cancer cell line, DHSF-BR16 70
Some suggestions from pk/pd principles to contain resistance in the clinical setting—focus on icu patients and gram-negative strains 68
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 68
Oxaliplatin plus Raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study 67
Vinorelbine in non-small cell lung cancer: Real-world data from a single-institution experience 66
Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study 66
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 66
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2′-pyridyl)benzimidazole as ligand: Comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives 66
Proteomic analysis of the cytotoxic effects induced by the organogold(iii) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 66
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 66
Postoperative chemotherapy in resected gastric cancer: Results of a single center experience 66
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? 65
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment 64
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(ii) compounds with sulfur and phosphorus donors 64
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 64
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 64
Genomic and genetic alterations infuence the progression of gastric cancer 64
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, In combination with cisplatin In patients with advanced non-small-cell lung cancer 64
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 63
Size dependent biological profiles of PEGylated gold nanorods 63
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma 63
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 62
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer 62
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand 62
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma 61
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipyc 60
Oxaliplatinum and 5-fluorouracil in protracted infusion in the treatment of advanced colorectal cancer 60
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 59
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules 59
Pharmacogenetics: Implementing personalized medicine 57
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 55
The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways 55
Gold compounds as anticancer agents: Chemistry, cellular pharmacology, and preclinical studies 55
Focus on biochemical and clinical predictors of response to immune checkpoint inhibitors in metastatic urothelial carcinoma: Where do we stand? 55
Editorial: Multidrug resistance in cancer: Pharmacological strategies from basic research to clinical issues 54
Emerging drugs in refractory colorectal cancer 54
Pharmacological strategies for overcoming multidrug resistance 54
Role of ATP-binding cassette transporters in cancer initiation and progression 53
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 53
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 52
Exploring the biochemical mechanisms of cytotoxic gold compounds: A proteomic study 50
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer 49
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 48
Increased Expression of VANGL1 is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature 48
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 47
Maintenance in gastric cancer: New life for an old issue? 46
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials 43
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery 42
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 39
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 39
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 37
Totale 6.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/2022214 1 4 3 2 4 0 2 21 28 6 50 93
2022/2023568 98 98 79 1 3 147 68 21 44 6 3 0
2023/2024304 12 27 20 18 12 82 98 0 0 5 8 22
2024/20251.419 103 464 295 11 37 8 43 39 163 65 96 95
2025/20263.840 173 266 471 575 213 146 351 187 964 287 172 35
Totale 6.799